<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To assess the prevalence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in patients with occlusive <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS: Seventy-five consecutive patients (44 with central <z:chebi fb="46" ids="15035">retinal</z:chebi> vein occlusions, 24 with branch venous occlusions, five with <z:hpo ids='HP_0002633'>vasculitis</z:hpo> plus branch venous occlusion, and two with <z:mp ids='MP_0006134'>arterial occlusions</z:mp>) were screened for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> and compared with a control group composed of outpatients with similar systemic <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disorders</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: The antibody assay for one patient was positive for <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and the antibody assay for three other patients was positive for anticardiolipin antibodies </plain></SENT>
<SENT sid="3" pm="."><plain>These four patients had central or branch <z:chebi fb="46" ids="15035">retinal</z:chebi> vein occlusion and presented with several vascular risk factors </plain></SENT>
<SENT sid="4" pm="."><plain>Comparison of the <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> and the control groups showed no difference in the levels of anticardiolipin antibodies or <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> did not seem to be a feature of <z:chebi fb="46" ids="15035">retinal</z:chebi> vein occlusion, but in rare cases (5%) they may contribute to the occlusive phenomenon </plain></SENT>
<SENT sid="6" pm="."><plain>A systematic screening does not seem to be justified, but it may be valuable to test for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in patients without conventional risk factors and in patients with clotting screen abnormalities, particularly if associated with <z:e sem="disease" ids="C0919715" disease_type="Disease or Syndrome" abbrv="">lupus-like syndrome</z:e> or other elements of the <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> </plain></SENT>
</text></document>